Coronavirus treatment: Psoriasis injection okayed for limited use

DCGI approves monoclonal antibody injection Itolizumab for restricted emergency use for the treatment of ‘cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19

from Livemint - News https://ift.tt/38LMh8Z
https://ift.tt/eA8V8J